Geoffrey D E Cuvelier
Overview
Explore the profile of Geoffrey D E Cuvelier including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
648
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pham-Huy A, Murguia-Favela L, Rubin T, Suresh S, Wright N, Derfalvi B, et al.
Paediatr Child Health
. 2025 Mar;
30(1):40-47.
PMID: 40061245
Objectives: Inborn errors of immunity (IEI) are a heterogeneous group of genetic diseases that impact normal immune development and function. Individual IEI are rare, but collectively, can represent an important...
2.
Khandelwalhl P, Khandelwal P, Fish J, Gorfinkel L, Guilcher G, Howell J, et al.
Transplant Cell Ther
. 2025 Feb;
PMID: 39952365
Chronic graft-versus-host disease (cGVHD) has a profound impact on the endocrinologic and cardiovascular health of survivors of transplantation performed in childhood. The impact of cGVHD is long-lasting and contributes to...
3.
Davila Saldana B, Davila Saldana B, Davila S, Schultz K, Schultz K, Ramgopal A, et al.
Transplant Cell Ther
. 2025 Jan;
PMID: 39855565
While highly morbid forms of chronic graft versus host disease (cGVHD) and severe late effects of allogeneic hematopoietic cell transplantation (HCT) can impact children and adults alike, unique considerations arise...
4.
Rotz S, Wiener L, Baker K, Choi S, Phelan R, Cuvelier G, et al.
Transplant Cell Ther
. 2024 Dec;
PMID: 39733839
Chronic graft-versus-host disease (cGVHD) occurs in approximately 1 in 5 pediatric allogeneic HCT patients and is a leading cause of late morbidity and mortality. Late effects of hematopoietic cell transplantation...
5.
Bhatt N, Harris A, Gorfinkel L, Ibanez K, Tkaczyk E, Mitchell S, et al.
Transplant Cell Ther
. 2024 Dec;
31(2):69.e1-69.e18.
PMID: 39701289
Current literature lacks details on the impact of pediatric chronic graft-versus-host disease (cGVHD) on long-term survivorship after allogeneic hematopoietic cell transplantation (HCT). Nonetheless, cGVHD remains a leading cause of post-transplant...
6.
Bognar T, Garcia-Rosa M, Lalmohamed A, Gungor T, Hauri-Hohl M, Prockop S, et al.
Blood Adv
. 2024 Jul;
8(19):5137-5145.
PMID: 39074263
Allogeneic hematopoietic cell transplantation (HCT) is a potentially curative treatment strategy for patients with inborn errors of immunities (IEIs). The objective of this study was to assess the optimal busulfan...
7.
Zinter M, Dvorak C, Mayday M, Reyes G, Simon M, Pearce E, et al.
Nat Med
. 2024 May;
30(7):1982-1993.
PMID: 38783139
Hematopoietic cell transplantation (HCT) uses cytotoxic chemotherapy and/or radiation followed by intravenous infusion of stem cells to cure malignancies, bone marrow failure and inborn errors of immunity, hemoglobin and metabolism....
8.
Huang R, McMahon K, Wang S, Chui H, Lebel A, Lee J, et al.
Kidney360
. 2024 Apr;
5(6):821-833.
PMID: 38668904
No abstract available.
9.
Abraham R, Basu A, Heimall J, Dunn E, Yip A, Kapadia M, et al.
Clin Immunol
. 2024 Feb;
261:109942.
PMID: 38367737
Severe combined immunodeficiency (SCID) is characterized by a severe deficiency in T cell numbers. We analyzed data collected (n = 307) for PHA-based T cell proliferation from the PIDTC SCID...
10.
Zinter M, Dvorak C, Mayday M, Reyes G, Simon M, Pearce E, et al.
medRxiv
. 2023 Dec;
PMID: 38077035
Lung injury is a major determinant of survival after pediatric hematopoietic cell transplantation (HCT). A deeper understanding of the relationship between pulmonary microbes, immunity, and the lung epithelium is needed...